The selective advantage of microbial fratricide.
Gilmore
M S
MS
Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, 20 Staniford Street, Boston, MA 02114, USA. mgilmore@vision.eri.harvard.edu
Haas
W
W
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins / Q000378:metabolism; D001430:Bacteriocins / Q000378:metabolism*; D001433:Bacteriolysis / Q000502:physiology*; D004247:DNA / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000378:metabolism; D024881:Drug Resistance, Bacterial / Q000502:physiology*; D008954:Models, Biological; D015398:Signal Transduction / Q000502:physiology; D013296:Streptococcus pneumoniae / Q000378:metabolism / Q000472:pathogenicity / Q000502:physiology*; D013301:Streptolysins / Q000378:metabolism
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D001430:Bacteriocins; C061262:ComA protein, Bacteria; D004268:DNA-Binding Proteins; D013301:Streptolysins; C032290:plY protein, Streptococcus pneumoniae; D004247:DNA